VERVE Enrollment Criteria
- Age > 50 years
- Current use of a TNF inhibitor (for any indication)
- No previous vaccination with Zostavax®
- Systemic glucocorticoid use (up to 10 mg prednisone per day) allowed
- Must have lived in the US for at least 30 years; or have a past history of Chicken Pox
- Visit the VERVE study at ClinicalTrials.gov “A service of the U.S. National Institutes of Health”
Interested in joining the VERVE team? Contact the UAB VERVE Study at (205) 934-2993 or email verve@uab.edu